Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient.

Infection

Assistance Publique Hôpitaux de Paris, Département de Médecine Interne, Hôpital Bichat-Claude Bernard, Université de Paris, 46 rue Henri Huchard, 75018, Paris, France.

Published: October 2020

In non-human immunodeficiency virus (HIV)-infected patients, tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) is unusual. The management of corticosteroids-refractory IRIS is unclear. We report on infliximab efficacy for treatment of corticosteroid-resistant TB-IRIS occurring in an immunocompetent patient.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15010-020-01470-zDOI Listing

Publication Analysis

Top Keywords

tuberculosis immune
8
immune reconstitution
8
reconstitution inflammatory
8
inflammatory syndrome
8
immunocompetent patient
8
infliximab corticosteroid-resistant
4
corticosteroid-resistant tuberculosis
4
syndrome tb-iris
4
tb-iris immunocompetent
4
patient non-human
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!